CAREPATHRx
End-to-end pharmacy solutions for health systems.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor | €0.0 | round |
| N/A | €0.0 | round | |
* | N/A | - | |
| Total Funding | 000k | ||
Related Content
CarepathRx offers comprehensive pharmacy and medication management solutions tailored for hospitals, health systems, physicians, and pharmacies. Founded in 2019 by John Figueroa and private equity firm Nautic Partners, the company aims to transform hospital pharmacy operations from a cost center into a revenue-generating care management strategy. Figueroa has a background leading several healthcare companies, including Genoa, Apria Healthcare Group, and Coram LLC.
The company's business model is centered on partnering with healthcare providers to fully integrate and manage their pharmacy operations. It offers an end-to-end service suite that includes specialty pharmacy, home and ambulatory infusion, telepharmacy, and technology solutions. This approach is designed to improve patient outcomes, expand service offerings, and create new revenue streams for its partners. CarepathRx serves a diverse client base, including over 600 hospitals and more than 15 health systems. Revenue is generated by providing a combination of technology, clinical pharmacy services, and wrap-around support to optimize pharmacy performance.
Core services include the development and management of home infusion and specialty pharmacy programs, which can be operational within six months. The company provides infrastructure, payor contracts, accreditation support, and data analytics. Its solutions cover patient onboarding, revenue cycle management, and clinical support. Additionally, CarepathRx offers telepharmacy services for remote order reviews and patient counseling, and solutions for managing polypharmacy in chronically ill patients. In December 2020, CarepathRx acquired the management services organization of UPMC's Chartwell pharmacy subsidiary in a $400 million deal, with UPMC becoming a strategic investor. The company later sold its specialty pharmacy subsidiary, BioPlus, to Elevance Health in a transaction announced in late 2022 and completed in 2023.
Keywords: pharmacy management solutions, hospital pharmacy services, medication management, specialty pharmacy, home infusion services, telepharmacy, patient therapy management, healthcare technology, 340B optimization, clinical pharmacy services, revenue cycle management, polypharmacy solutions, medication adherence, health system partnerships, outpatient infusion, ambulatory infusion, pharmacy benefit management, care transition management, limited distribution drugs, pharmacy accreditation